Solana Company · NASDAQ:HSDT
Solana — Helius Medical Technologies — Investor Presentation (September 2025)
23 slides from Solana's investor presentation, Sep 15, 2025
Slide 1: Project Sumtera Investor Presentation
Strictly Private & Confidential Project Sumtera Investor Presentation September 2025
Slide 2: Disclaimer
2 Strictly Private & Confidential Disclaimer This presentation has been prepared by Helius Medical Technologies, Inc. (“Helius” or the “Company”) solely for information p urp oses. The information contained in this presentation has been prepared solely to assist interested parties in making their ow
Slide 3: II. Why Solana I. Executive Summary IV. Appendix III. Opportunity Overview 12
Strictly Private & Confidential Strictly Private & Confidential II. Why Solana 7 I. Executive Summary 4 IV. Appendix 20 III. Opportunity Overview 12
Slide 4: I. Executive Summary
Strictly Private & Confidential Strictly Private & Confidential I. Executive Summary
Slide 5: Project Sumtera: Accelerating Solana Adoption
5 Strictly Private & Confidential Finalizing LOI with und ation Project Sumtera: Accelerating Solana Adoption Combining DAT Expertise, Leading Capital Markets Execution, and Unique US + Asia Distribution Project Sumtera will partner with Pantera Capital and Summer Capital to create a market leading
Slide 6: Transaction Summary
6 Strictly Private & Confidential Transaction Summary ▪ Helius Medical Technologies, Inc. (NASDAQ: HSDT) Ticker / Issuer ▪ $500M Common Equity PIPE ▪ 1:1 Stapled Warrants ▪ $1,245M Total Notional Value Capital Raise ▪ One stapled warrant per share of Common Equity purchased ▪ Warrants exercisable fo
Slide 7: II. Why Solana
Strictly Private & Confidential Strictly Private & Confidential II. Why Solana
Slide 8: Why Solana
8 Strictly Private & Confidential ▪ ~3,500+ transactions per second with <400ms finality and consistent uptime ▪ <$0.01 fees per transaction that enables high volume activities The Fastest Blockchain ▪ 7,500+ new developers onboarded in 2024 ▪ 3.7M+ average daily active wallets with 23B+ transaction
Slide 9: Solana is the Leading Blockchain Platform
9 Strictly Private & Confidential is the Leading Blockchain Platform 40 50 60 70 80 90 100 110 120 Jan-24 Apr-24 Jul-24 Oct-24 Jan-25 Apr-25 Jul-25 0 2 4 6 8 Jan-24 Apr-24 Jul-24 Oct-24 Jan-25 Apr-25 Jul-25 0% 20% 40% 60% 80% 100% Jan-24 Apr-24 Jul-24 Oct-24 Jan-25 Apr-25 Jul-25 SOL REV ETH REV 0 20
Slide 10: Solana is Being Adopted by Financial Institutions and FinTech Giants
10 Strictly Private & Confidential is Being Adopted by Financial Institutions and FinTech Giants ▪ #6 blockchain by real world assets (RWA) market share with $500M assets tokenized (1) ▪ BlackRock and Franklin Templeton launched tokenized MMFs on Solana Supported By: Real World Asset Tokenization ▪
Slide 11: Solana's Institutional Adoption at Inflection Point
11 Strictly Private & Confidential chipper ’s Institutional Adoption at Inflection Point Solana Ethereum Bitcoin Metric 606,327,009 120,710,562 19,899,396 Total Supply 5,209,195 8,164,604 3,096,459 Total Institutional Holdings 3,440,000 2,329,611 1,742,781 Treasury Holdings 1,769,195 5,834,993 1,353
Slide 12: III. Opportunity Overview
Strictly Private & Confidential Strictly Private & Confidential III. Opportunity Overview
Slide 13: Project Sumtera's Core Engine: Maximizing SOL per Share
13 Strictly Private & Confidential Holding Spot Project Sumtera Project Sumtera’s Core Engine: Maximizing SOL per Share Solana - per - Share Growth (SPS) mNAV Expansion Token Price Increase Anticipated Strategy of Project Sumtera 1. Capital Markets Activity ▪ Issue stock at a premium ▪ Monetize vola
Slide 14: Case Study: BitMine Immersion Technologies (BMNR)
14 Strictly Private & Confidential Case Study: BitMine Immersion Technologies (BMNR) ▪ BitMine Immersion (BMNR) launched in late June; Pantera was a strategic anchor investor ▪ BMNR has become the largest ETH DAT with 1.7M ETH acquired ▪ BMNR has returned ~12x for PIPE investors in 2 months and Proj
Slide 15: DATs Can Trade Above 1.0x mNAV
15 Strictly Private & Confidential DATs Can Trade Above 1.0x mNAV Source: Bloomberg, Coingecko, Pantera Capital Analysis, Summer Capital Analysis as of August 29, 2025 Note: All figures are shown in USD unless otherwise indicated. There can be no assurance that investments made in the future will ha
Slide 16: Attractive Entry Point
16 Strictly Private & Confidential Attractive Entry Point Company $13.55 $7.29 $7.23 $16.02 ~$6.88 Current Share Price $1,419M $161M $681M $630M ~$560M Pro Forma Market Cap - 420,706 2,000,518 1,831,011 ~2,500,000 # SOL Owned $693M $84M $400M $491M ~$500M $ SOL Owned 2.0x 1.9x 1.7x 1.3x ~0.9x Implie
Slide 17: The Company's New Directors and Advisory Board
17 Strictly Private & Confidential The Company’s New Directors and Advisory Board New Director Nominees New Advisory Board Leadership team to be enhanced with new additions to the Board of Directors as well as creation of new Advisory Board ▪ Founder & Chairman of Summer Capital ▪ Vice Chairman of A
Slide 18: HSDT at a Glance
18 Strictly Private & Confidential HSDT - at - a - Glance Overview Product Overview ▪ Founded in 2018 as a medical device company ▪ Headquartered in Newtown, PA with ~22 employees ▪ $0.0 million in revenue for the quarter ending June 30, 2025 ▪ ($8.8) million in net debt as of September 9, 2025 ▪ 80
Slide 19: HSDT Management Team and Board of Directors
19 Strictly Private & Confidential HSDT Management Team and Board of Directors Management Team Board of Directors Edward M. Straw Director Paul Buckman Director Blane Walter Chairman of the Board Sherry Perkins Director Dane C. Andreeff Executive Director Jeffrey S. Mathiesen Executive Director Dane
Slide 20: IV. Appendix
Strictly Private & Confidential Strictly Private & Confidential IV. Appendix
Slide 21: Risk Factors
21 Strictly Private & Confidential Risk Factors ▪ The Company’s financial results and the market price of the Company’s shares of common equity may be affected by the prices o f S OL. ▪ Investing in SOL will expose the Company to certain risks associated with SOL, such as price volatility, limited l
Slide 22: Risk Factors (cont'd)
22 Strictly Private & Confidential Risk Factors (cont’d) ▪ The Company may be required to obtain the affirmative vote of shareholders in order to consummate this transaction. ▪ The Company intends to use the net proceeds from this offering to purchase SOL, the price of which has been, and will likel
Slide 23: Thank You
Thank You Strictly Private & Confidential
Helius Medical Technologies — Investor Presentation (September 2025) on 6ix